NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their RightsApril 27, 2026
Share Twitter Facebook LinkedIn Email Prime Minister Mark Carney spoke to his U.S. counterpart by phone Thursday — the first time the leaders have spoken since the two sides failed to reach a deal on a trade agreement earlier this month.Read More